• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

取代高异黄酮对肠道病毒的抗病毒活性。

Antiviral activity of substituted homoisoflavonoids on enteroviruses.

作者信息

Tait Sabrina, Salvati Anna Laura, Desideri Nicoletta, Fiore Lucia

机构信息

Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome 00161, Italy.

出版信息

Antiviral Res. 2006 Dec;72(3):252-5. doi: 10.1016/j.antiviral.2006.07.003. Epub 2006 Jul 28.

DOI:10.1016/j.antiviral.2006.07.003
PMID:16934879
Abstract

The antiviral activity of homoisoflavonoids, a class of flavonoids, was determined in vitro against a large panel of enteroviruses. The inhibition of viral replication was monitored on BGM (Buffalo Green Monkey) cells, and the concentration required for 50% inhibition (IC50), as well as the selectivity index (SI) were determined. None of the substances were effective against Sabin type 1 poliovirus (PV1), but most of them showed a low cytotoxicity and a marked antiviral activity against Coxsackie virus B1, B3, B4, A9 and echovirus 30.

摘要

一类黄酮类化合物即高异黄酮类化合物的抗病毒活性在体外针对大量肠道病毒进行了测定。在BGM(水牛绿猴)细胞上监测病毒复制的抑制情况,并确定50%抑制所需浓度(IC50)以及选择性指数(SI)。这些物质均对1型萨宾脊髓灰质炎病毒(PV1)无效,但它们中的大多数显示出低细胞毒性以及对柯萨奇病毒B1、B3、B4、A9和埃可病毒30具有显著的抗病毒活性。

相似文献

1
Antiviral activity of substituted homoisoflavonoids on enteroviruses.取代高异黄酮对肠道病毒的抗病毒活性。
Antiviral Res. 2006 Dec;72(3):252-5. doi: 10.1016/j.antiviral.2006.07.003. Epub 2006 Jul 28.
2
Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan.6-恶唑啉基异黄酮的手性识别及抗小RNA病毒活性
Chirality. 1993;5(5):356-8. doi: 10.1002/chir.530050515.
3
9-Arylpurines as a novel class of enterovirus inhibitors.9-芳基嘌呤类作为新型肠道病毒抑制剂。
J Med Chem. 2010 Jan 14;53(1):316-24. doi: 10.1021/jm901240p.
4
The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.7-羟基异黄酮对肠道病毒71型的体外抗病毒作用。
J Asian Nat Prod Res. 2013;15(4):382-9. doi: 10.1080/10286020.2013.770737. Epub 2013 Mar 6.
5
[Inhibition of the multiplication of a Coxsackie A9 strain isolated from a patient with epidemic neuropathy by the interferons alfa and gamma].[α干扰素和γ干扰素对从一名流行性神经病患者分离出的柯萨奇A9毒株增殖的抑制作用]
Rev Cubana Med Trop. 1994;46(1):13-5.
6
Combating enterovirus replication: state-of-the-art on antiviral research.抗病毒研究的最新进展:对抗肠道病毒复制。
Biochem Pharmacol. 2012 Jan 15;83(2):185-92. doi: 10.1016/j.bcp.2011.08.016. Epub 2011 Aug 26.
7
Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.2-取代基-1H-苯并咪唑-4-甲酰胺衍生物对肠道病毒的抑制特性。
Bioorg Med Chem. 2011 Apr 15;19(8):2641-9. doi: 10.1016/j.bmc.2011.03.007. Epub 2011 Mar 10.
8
[In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].[新型抗病毒物质的体外有效性。2. 肠道病毒和鼻病毒1B的研究]
Virologie. 1985 Apr-Jun;36(2):111-7.
9
Antiviral activity of naphthoquinones. I. Lapachol derivatives against enteroviruses.萘醌类化合物的抗病毒活性。I. 拉帕醇衍生物对肠道病毒的作用
Rev Latinoam Microbiol. 1986 Jul-Sep;28(3):221-5.
10
Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.N-芳基乙基异喹啉衍生物的合成、结构-活性关系及体外生物学评价作为柯萨奇病毒 B3 抑制剂。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5787-90. doi: 10.1016/j.bmcl.2011.08.002. Epub 2011 Aug 8.

引用本文的文献

1
Regulation of Matrix Metalloproteinases by Wine-Derived Compounds: Implications for Cancer Therapy.葡萄酒衍生化合物对基质金属蛋白酶的调节作用:对癌症治疗的启示
Biomolecules. 2025 May 28;15(6):781. doi: 10.3390/biom15060781.
2
Local and Systemic Effects of Bioactive Food Ingredients: Is There a Role for Functional Foods to Prime the Gut for Resilience?生物活性食品成分的局部和全身效应:功能性食品在增强肠道恢复力方面能发挥作用吗?
Foods. 2024 Feb 28;13(5):739. doi: 10.3390/foods13050739.
3
Screening and selection of essential oils for an intranasal spray against bovine respiratory pathogens based on antimicrobial, antiviral, immunomodulatory, and antibiofilm activities.
基于抗菌、抗病毒、免疫调节和抗生物膜活性筛选和选择用于抗牛呼吸道病原体的鼻内喷雾剂的精油。
Front Vet Sci. 2024 Feb 7;11:1360398. doi: 10.3389/fvets.2024.1360398. eCollection 2024.
4
Redox-neutral and metal-free synthesis of 3-(arylmethyl)chroman-4-ones visible-light-driven alkene acylarylation.3-(芳基甲基)色满-4-酮的氧化还原中性无金属合成:可见光驱动的烯烃酰基芳基化反应
Front Chem. 2022 Oct 31;10:1059792. doi: 10.3389/fchem.2022.1059792. eCollection 2022.
5
Synthesis of Coumarin and Homoisoflavonoid Derivatives and Analogs: The Search for New Antifungal Agents.香豆素和高异黄酮衍生物及类似物的合成:新型抗真菌剂的探索
Pharmaceuticals (Basel). 2022 Jun 3;15(6):712. doi: 10.3390/ph15060712.
6
Inhibitory mechanism of two homoisoflavonoids from on tyrosinase activity: insight from spectroscopic analysis and molecular docking.两种来自[具体来源未给出]的高异黄酮对酪氨酸酶活性的抑制机制:光谱分析和分子对接的见解
RSC Adv. 2021 Oct 22;11(54):34343-34354. doi: 10.1039/d1ra06091k. eCollection 2021 Oct 18.
7
Chromanone-A Prerogative Therapeutic Scaffold: An Overview.色满酮 - A:一种具有优势的治疗性骨架:综述。
Arab J Sci Eng. 2022;47(1):75-111. doi: 10.1007/s13369-021-05858-3. Epub 2021 Jun 30.
8
Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2.对茶、刺蒺藜、儿茶、柠檬、黑胡椒的生物活性成分以及合成化合物与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的主要蛋白酶(Mpro)和人血管紧张素转换酶2(ACE 2)进行虚拟筛选。
Futur J Pharm Sci. 2021;7(1):121. doi: 10.1186/s43094-021-00275-7. Epub 2021 Jun 15.
9
In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M).计算机模拟研究某些异黄酮类化合物作为针对 COVID-19 人类 ACE2(hACE2)和病毒主要蛋白酶(M)的潜在候选药物
Molecules. 2021 May 10;26(9):2806. doi: 10.3390/molecules26092806.
10
A Comprehensive Review on Chemotaxonomic and Phytochemical Aspects of Homoisoflavonoids, as Rare Flavonoid Derivatives.同型异黄酮类化合物作为罕见的黄酮类衍生物的化学分类学和植物化学综述。
Int J Mol Sci. 2021 Mar 8;22(5):2735. doi: 10.3390/ijms22052735.